Transformative
Patient Care

Innovative Pharmaceutical Solutions

RAM Pharmaceuticals is dedicated to developing innovative pharmaceutical solutions that enhance patient comfort and care. Our commitment to addressing the unmet needs in healthcare drives us to create products that provide effective relief and improve patients’ quality of life.

RAMTherapeutics is at the forefront of innovation in cancer care, focusing on developing novel therapies to reduce the incidence and severity of severe oral mucositis (SOM) in cancer patients undergoing radiation and chemotherapy. Our groundbreaking medication, Triamdocaine™, is specifically formulated to address this painful side effect affecting thousands of patients. Triamdocaine has received FDA IND approval and is currently in Phase 2 clinical trials, reflecting our dedication to transforming cancer treatment with effective therapeutic solutions. Additionally, through our Cancer Comfort Care initiative, we aim to enhance patient support and comfort by providing effective pharmaceutical solutions that cater to the unique challenges faced by cancer patients.

At RAMDental, we specialize in providing cutting-edge compounded medications designed to alleviate dental pain and manage oral health conditions. Our flagship product, Acyclonine Mum™, is a 503B compounded medication that offers temporary relief from intense discomfort associated with various oral conditions. This product is particularly effective for managing symptoms linked to acute and chronic oral mucosal ulcerations, post-operative pain, traumatic dental injuries, aphthous ulcers, abscesses, necrotizing diseases, lichen planus, pemphigus, and stomatitis. We are committed to advancing dental care through our innovative solutions and supporting healthcare providers in delivering optimal patient outcomes.

Testimonials

Scroll to Top

Partner With Us

Join us on the ground floor of a transformative journey with RAM Pharmaceuticals.

As we lead the charge in developing groundbreaking treatments for Severe Oral Mucositis and dental pain management, this is your chance to invest in a company poised for exponential growth. With FDA-approved innovations and a commitment to enhancing patient comfort, RAM Pharmaceuticals is setting new standards in the pharmaceutical industry.

Mark your calendars!

Starting December 15th, 2024, you can invest through StartEngine and be part of a profitable mission that makes a profound difference in the lives of countless cancer patients. Don’t miss your opportunity to be a catalyst for change!